Professor Stephen McMahon and Dr Franziska Denk from the Wolfson Centre for Age-Related Diseases have been awarded EUR 450,000, as part of a new European research consortium funded by the Innovative Medicine Initiative (IMI2).
The consortium, named NGN-PET, brings together partners from industry and academia and has a total budget of 3.3 million Euros over three years. It aims to develop a system that models pain in a dish and can help drug discovery. In particular, NGN-PET will try to develop a high-throughput drug screening platform to study sensory neurons derived from human stem cells grown together with their supporting glial cells.
The team at King’s is involved in finding out which glial cell types and drug targets might be worth studying in the novel human co-culture system.